You are here: Home » Current Affairs » Coronavirus » News
Business Standard

Covid-19: AstraZeneca opens research centre as UK builds science hub

Prince Charles will be on hand Tuesday when pharmaceutical company AstraZeneca opens a 1 billion-pound research centre near the University of Cambridge

Topics
Coronavirus Vaccine | AstraZeneca

AP  |  London 

Astrazeneca
Photo: Bloomberg

Prince Charles will be on hand Tuesday when pharmaceutical company opens a 1 billion-pound ($1.34 billion) research centre near the University of Cambridge, hoping to build on work in developing one of the first COVID-19 vaccines.

The 19,000 square-meter (more than 200,000 square-foot) complex will house more than 2,200 research scientists. It joins a cluster of businesses seeking to make Cambridge a hub for life sciences research similar to what California's Silicon Valley is for the technology industry.

Our ambition today is to not only unveil a building, but to also drive the next wave of scientific innovation, CEO Pascal Soriot said in a statement.

The Cambridge life sciences cluster includes 631 companies that employ almost 21,000 people and generate annual revenue of 7 billion pounds, according to Cambridge Ahead, which promotes business development in the city.

worked with Oxford University to develop one of the first COVID-19 vaccines approved by regulators in the U.K., European Union and other countries. The vaccine is widely used in developing nations because has pledged to keep costs down by selling it to low- and middle-income countries on a non-profit basis.

AstraZeneca also plans to ask the U.S. Food and Drug Administration to approve the vaccine.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Tue, November 23 2021. 17:28 IST
RECOMMENDED FOR YOU